New York Times: Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It. "With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients." (GIFT ARTICLE) https://www.nytimes.com/2024/01/04/health/paxlovid-covid-treatment.html?searchResultPosition=1 #GiftArticle #covid19 #CovidIsNotOver #pandemic #paxlovid
@ai6yr I'd take it if I could walk to the pharmacy and buy it, like in civilized countries. Lol.
@ai6yr BTW, I'm in the middle of my second round of Covid. Had it two years ago. I'm fully vaxxed and boosted with the lastest as of 30 days ago so I'm guessing it's the JN.1 variant.
@shuttersparks Oh man, hope you feel better soon! Quite a few people on round 2 that I know in the last month (Started around Thanksgiving... finally tailing off a bit right now, at least based on the folks I am hearing in my immediate circle).
@ai6yr I assumed it was one of the XBB variants but then looked at the data. JN.1 is off to a supersonic start, accounting for 43 percent of new cases right now. That means a big surge is coming. Models predict it to peak at the end of January. And JN.1 has a new spike protein so it gets around all the vaccines.
We shall see said the blind man.
@shuttersparks Yep, I would think so.